| Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|
| transaction | GYRE | Common Stock | Sale | -$21.6K | -2K | -0.07% | $10.82 | 2.94M | Dec 19, 2024 | By Spouse | F1, F2 |
| transaction | GYRE | Common Stock | Sale | -$21.8K | -2K | -0.07% | $10.90 | 2.93M | Dec 20, 2024 | By Spouse | F1, F3 |
Buy Plan / Sale Plan: These are also open market purchases/sales of shares, but in this case the transaction is part of a trading plan. Rule 10b5-1 allows insiders to setup a trading plan to buy/sell stocks over a certain period of time. Since the purchases/sales are predetermined, this protects the insiders from violating insider trading law.
Transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c).
| Id | Content |
|---|---|
| F1 | This transaction was executed pursuant to a Rule 10b5-1 trading plan adopted on September 13, 2024. |
| F2 | The price reported represents the weighted average sale price per share. The shares were sold in multiple transactions at prices ranging from $10.61 to $11.35. Upon request by the staff of the U.S. Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, the Reporting Person will provide full information regarding the number of shares sold at each separate price. |
| F3 | The price reported represents the weighted average sale price per share. The shares were sold in multiple transactions at prices ranging from $10.39 to $11.11. Upon request by the staff of the U.S. Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, the Reporting Person will provide full information regarding the number of shares sold at each separate price. |